SEC Form D · Amendment · filed June 28, 2022
Centrexion Therapeutics Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Shawn R. Tomasello · BOSTON, MADirectorRandall M. Stevens · BOSTON, MAExecDezhi J. Kang, Ph.D · BOSTON, MADirectorSol J. Barer · BOSTON, MADirectorMichael J. Ward · BOSTON, MAExecJames N. Campbell, M.D · BOSTON, MAExec · DirectorJoseph R. Swedish · BOSTON, MADirectorColin J. Hill · BOSTON, MADirectorJ. C. Lopez, M.D · BOSTON, MADirectorJeffrey B. Kindler · BOSTON, MAExec · DirectorPeter R. Wirth · Boston, MADirectorBrian Bannister · Casper, WYDirectorJeffry D. Elliott · Bay Village, OHExecTom Mcgovern · Bloomfield Hills, MIExec · DirectorJosh Phair · Casper, WYDirectorMark Hartig · Casper, WYExec · DirectorErik Tuveson · Northborough, MADirectorClyde D. Cady · Bay Village, OHExecGary Bechtel · Bloomfield Hills, MIDirectorRaymond Davis · Bloomfield Hills, MIDirectorSarah Robertson · Denver, CODirectorBrook Scardina · Bloomfield Hills, MIDirectorTaylor Frankel · Teton Village, WYDirectorGabriel E. Felzenszwalb · Rio de Janeiro, GuernseyDirectorAlessandro Horta · Rio de Janeiro, GuernseyExec · DirectorBruno A. Sacchi Zaremba · Rio de Janeiro, GuernseyDirectorCarlos E. Martins E Silva · Rio de Janeiro, GuernseyExecCindy W. Kim · Seattle, WAExecRobert Monk · Reston, VAExec · DirectorKevin Cunningham · Reston, VADirectorEugene Park · Reston, VADirectorDarragh J. Murphy · Camana Bay, Grand Cayman, Cayman IslandsDirectorHartej Jagdev · Grand Cayman, Cayman IslandsDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗